share_log

Doximity | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Morgan Stanley(5.7%),Morgan Stanley Investment Management Inc.(5.2%)

SEC announcement ·  Feb 8 10:50
Summary by Moomoo AI
Morgan Stanley has filed an amended Schedule 13G with the United States Securities and Exchange Commission, indicating a change in its holdings in Doximity, Inc. As of December 31, 2023, Morgan Stanley reported shared voting power over 6,138,353 shares and shared dispositive power over 6,723,602 shares of Doximity's Class A Common Stock. Morgan Stanley Investment Management Inc., a subsidiary of Morgan Stanley, reported shared voting power over 5,720,180 shares and shared dispositive power over 6,199,284 shares. The aggregate amount beneficially owned by Morgan Stanley is 6,749,692 shares, representing 5.7% of the class, while Morgan Stanley Investment Management Inc. holds 6,199,284 shares, representing 5.2% of the class. The filing, dated February 8, 2024, confirms that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Doximity.
Morgan Stanley has filed an amended Schedule 13G with the United States Securities and Exchange Commission, indicating a change in its holdings in Doximity, Inc. As of December 31, 2023, Morgan Stanley reported shared voting power over 6,138,353 shares and shared dispositive power over 6,723,602 shares of Doximity's Class A Common Stock. Morgan Stanley Investment Management Inc., a subsidiary of Morgan Stanley, reported shared voting power over 5,720,180 shares and shared dispositive power over 6,199,284 shares. The aggregate amount beneficially owned by Morgan Stanley is 6,749,692 shares, representing 5.7% of the class, while Morgan Stanley Investment Management Inc. holds 6,199,284 shares, representing 5.2% of the class. The filing, dated February 8, 2024, confirms that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Doximity.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more